Boston Scientific Corp.

NYSE: BSX    
Share price (5/17/24): $74.65    
Market cap (5/17/24): $110 billion
45 Boston Scientific Corp. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Indentures Filter

EX-4.3
from 8-K 20 pages €[•] 3.500% Senior Notes Due 2032 American Medical Systems Europe B.V. Promises to Pay Usb Nominees (Uk) Limited or Registered Assigns the Aggregate Principal Sum of [•] Euros (€[•]) or Such Other Amount as Indicated on the Schedule of Increases or Decreases in the Global Note Attached Hereto, on March 8, 2032. Guaranteed by Boston Scientific Corporation
12/34/56
EX-4.2
from 8-K 20 pages €[•] 3.375% Senior Notes Due 2029 American Medical Systems Europe B.V. Promises to Pay Usb Nominees (Uk) Limited or Registered Assigns the Aggregate Principal Sum of [•] Euros (€[•]) or Such Other Amount as Indicated on the Schedule of Increases or Decreases in the Global Note Attached Hereto, on March 8, 2029. Guaranteed by Boston Scientific Corporation
12/34/56
EX-4.5
from 8-K 20 pages €[●] 1.875% Senior Notes Due 2034
12/34/56
EX-4.4
from 8-K 20 pages €[●] 1.625% Senior Notes Due 2031
12/34/56
EX-4.3
from 8-K 20 pages €[●] 1.375% Senior Notes Due 2028
12/34/56
EX-4.2
from 8-K 20 pages €[●] 0.750% Senior Notes Due 2025
12/34/56
EX-4.1
from 8-K 118 pages Boston Scientific Corporation and American Medical Systems Europe B.V., as Issuer or Guarantor, as Applicable, for Each Series of Securities From Time to Time and U.S. Bank Trust Company, National Association, as Trustee Indenture Dated as of March 8, 2022 Debt Securities Boston Scientific Corporation American Medical Systems Europe B.V. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of March 8, 2022 Trust Indenture Act Section Indenture Section
12/34/56
EX-4.2
from 10-K 47 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-3ASR 118 pages Boston Scientific Corporation American Medical Systems Europe B.V. [ ] as Issuer or Guarantor, as Applicable, for Each Series of Securities From Time to Time and U.S. Bank Trust Company, National Association, as Trustee Form of Indenture Dated as of [ ], 20[ ] Debt Securities Boston Scientific Corporation American Medical Systems Europe B.V. Reconciliation and Tie Between Trust Indenture Act of 1939 and Indenture, Dated as of [ ], 20[ ]
12/34/56
EX-4.2
from 10-K 47 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.3
from 8-K 12 pages $[●] 2.650% Senior Note Due 2030 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Dollars ($[●]) on June 1, 2030
12/34/56
EX-4.2
from 8-K 12 pages $[●] 1.900% Senior Note Due 2025 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Dollars ($[●]) on June 1, 2025
12/34/56
EX-4.2
from 10-K 13 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 15 pages €[●] 0.625% Senior Note Due 2027 Boston Scientific Corporation Promises to Pay to Usb Nominees (Uk) Limited or Registered Assigns the Principal Sum of [●] Euros (€[●]) on December 1, 2027
12/34/56
EX-4.6
from 8-K 12 pages [●] 4.700% Senior Note Due 2049 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Million Dollars ($[●]) on March 1, 2049
12/34/56
EX-4.5
from 8-K 12 pages [●] 4.550% Senior Note Due 2039 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Million Dollars ($[●]) on March 1, 2039
12/34/56
EX-4.4
from 8-K 12 pages [●] 4.000% Senior Note Due 2029 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Million Dollars ($[●]) on March 1, 2029
12/34/56
EX-4.3
from 8-K 12 pages [●] 3.750% Senior Note Due 2026 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Million Dollars ($[●]) on March 1, 2026
12/34/56
EX-4.2
from 8-K 12 pages [●] 3.450% Senior Note Due 2024 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of [●] Million Dollars ($[●]) on March 1, 2024
12/34/56
EX-4.2
from 8-K 23 pages $500,000,000 4.000% Senior Note Due 2028 Boston Scientific Corporation Promises to Pay to Cede & Co. or Registered Assigns the Principal Sum of Five Hundred Million Dollars ($500,000,000) on March 1, 2028
12/34/56